News RSS https://www.ebmt.org/ en EBMT and the EU Joint Action on Health Technology Assessment https://www.ebmt.org/ebmt/news/ebmt-and-eu-joint-action-health-technology-assessment <p><span><span><span>Following the <a href="/ebmt/news/ebmt-receives-regulatory-qualification-european-medicine-agency-ema-use-its-patient" target="_blank">positive qualification opinion issued by EMA on the EBMT registry module for cellular therapies</a> in February 2019, EBMT engaged in a similar </span></span></span></p> Eoin McGrath https://www.ebmt.org/ebmt/news/ebmt-and-eu-joint-action-health-technology-assessment Strategic Partnership: EBMT and EHA aim to position Europe in the lead of the global cellular therapy field with the new GoCART coalition https://www.ebmt.org/ebmt/news/strategic-partnership-ebmt-and-eha-aim-position-europe-lead-global-cellular-therapy-field <p><span><span><span><span lang="EN-US" lang="EN-US" lang="EN-US"><span>The field of cell and gene therapy is one of the most exciting developments in medicine.</span></span></span></span></span></p> https://www.ebmt.org/ebmt/news/strategic-partnership-ebmt-and-eha-aim-position-europe-lead-global-cellular-therapy-field EBMT 2020 Annual Meeting - Multi-stakeholder Forum on Innovative Cellular Therapies https://www.ebmt.org/ebmt/news/ebmt-2020-annual-meeting-multi-stakeholder-forum-innovative-cellular-therapies <p><span><span><span><strong><span lang="EN-GB" lang="EN-GB" lang="EN-GB"><span>Special Session - Monday 31 August, 09:30-10:30H, Auditorium 6</span></span></strong></span></span></span></p> https://www.ebmt.org/ebmt/news/ebmt-2020-annual-meeting-multi-stakeholder-forum-innovative-cellular-therapies EBMT receives a regulatory qualification from the European Medicine Agency (EMA) on the use of its patient registry to support novel CAR T-cell therapies. https://www.ebmt.org/ebmt/news/ebmt-receives-regulatory-qualification-european-medicine-agency-ema-use-its-patient <p><span><span><span><span><span lang="EN-US" lang="EN-US" lang="EN-US"><span><span>As a result of extensive interaction with the EMA that started in late 2016 when the EBMT responded to the </span></span></span><a href="https://www.ema.europa.eu/en/human-regulatory/post-authorisation/patien&lt;/body&gt;&lt;/html&gt;"></a></span></span></span></span></p> https://www.ebmt.org/ebmt/news/ebmt-receives-regulatory-qualification-european-medicine-agency-ema-use-its-patient